FDA authorizes Pfizer COVID-19 booster shot for individuals aged 12 to 15
by Lavanya Subramanian and Tiffany Chang
• January 15, 2022
Pfizer authorizes booster dose for 16, 17-year-olds
by Sabrina Zhu and Alysa Suleiman
• December 14, 2021
COVID-19 vaccination mandates enforced in New Zealand, Italy and United States
by Ananya Sriram and Brandon Zau
• November 30, 2021
FDA approves Pfizer, Moderna and Johnson & Johnson booster shots, administration currently underway
by Edward Huang, Reporter
• October 26, 2021
Moderna announces new ‘combo’ vaccine to combat COVID-19 and the flu
by Emma Gao and Kinnera Mulam
• September 18, 2021
Myth-busting COVID-19 and the vaccines
by Arjun Barrett and Nicole Tian
• August 28, 2021
FDA approves Pfizer’s COVID-19 vaccine
by Sabrina Zhu, STEM Editor
• August 27, 2021
Harker staff and students receive COVID-19 vaccinations, more scheduled this month
by Lucy Ge, Winged Post News Editor
• March 1, 2021
Vaccine distributions advance in the U.S., California receives 5.7 million doses
by Sabrina Zhu, Assistant STEM Editor
• February 1, 2021
Comparing the COVID-19 vaccines: Pfizer, Moderna and AstraZeneca
by Sabrina Zhu, Assistant STEM Editor
• January 15, 2021
3 COVID-19 vaccines move forward after promising Phase 3 clinical trial data
by Mark Hu and Sabrina Zhu
• December 2, 2020
SARS-CoV-2 vaccines continue Phase 3 trials, testing
by Aditya Singhvi, Aquila Co-Managing Editor
• September 28, 2020
Load More Stories